Tumor response to neoadjuvant chemoradiation in rectal cancer: predictor for surgical morbidity?

@article{Horisberger2007TumorRT,
  title={Tumor response to neoadjuvant chemoradiation in rectal cancer: predictor for surgical morbidity?},
  author={Karoline Horisberger and Ralf-Dieter Hofheinz and Paolo Palma and Angela Volkert and Simone Rothenhoefer and Frederik Wenz and Andreas Hochhaus and Stefan Post and Frank Willeke},
  journal={International Journal of Colorectal Disease},
  year={2007},
  volume={23},
  pages={257-264}
}
Increasing the rate of pathological complete remissions after neoadjuvant chemoradiation of rectal cancer has become a strategy to further improve the long-term oncological outcome of patients. This report evaluates the influence of preoperative intensified radiochemotherapy on the rate and outcome of surgical complications. Patients with primary rectal cancer at stages cT3/4cNx or N+ without metastasis were preoperatively treated either with capecitabine and irinotecan or with capecitabine… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 20 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 45 references

Similar Papers

Loading similar papers…